EP 1776120 A1 20070425 - NOVEL USES OF 2-PHENYL-SUBSTITUTED IMIDAZOTRIAZINONE DERIVATIVES
Title (en)
NOVEL USES OF 2-PHENYL-SUBSTITUTED IMIDAZOTRIAZINONE DERIVATIVES
Title (de)
NEUE VERWENDUNGEN VON 2-PHENYL-SUBSTITUIERTEN IMIDAZOTRIAZINON-DERIVATEN
Title (fr)
NOUVELLES UTILISATIONS DE DERIVES D'IMIDAZOTRIAZINONES SUBSTITUEES PAR 2-PHENYLE
Publication
Application
Priority
- EP 2005008057 W 20050723
- DE 102004038328 A 20040806
Abstract (en)
[origin: WO2006015715A1] The invention relates to the use of PDE 5 inhibitors, and especially of known 2-phenyl-substituted imidazotriazinone derivatives for producing medicaments for the treatment of symptoms that can be treated by increasing cGMP levels in certain tissues, such as acute myocardial infarction and damage caused by reperfusion, various symptoms in the female and male reproductive system and urogenital tract, gastrointestinal diseases, damage caused by diabetes, and liver failure.
IPC 8 full level
A61K 31/53 (2006.01); A61P 9/00 (2006.01); A61P 15/00 (2006.01); A61P 25/00 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP KR US)
A61K 31/53 (2013.01 - EP KR US); A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 1/10 (2017.12 - EP); A61P 1/16 (2017.12 - EP); A61P 1/18 (2017.12 - EP); A61P 3/06 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 5/24 (2017.12 - EP); A61P 7/00 (2017.12 - EP); A61P 7/02 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 13/00 (2017.12 - EP); A61P 13/02 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 15/06 (2017.12 - EP); A61P 15/08 (2017.12 - EP); A61P 15/10 (2017.12 - EP); A61P 15/14 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 17/02 (2017.12 - EP); A61P 17/14 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 21/02 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/06 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 27/12 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 35/02 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 2006015715A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
HR
DOCDB simple family (publication)
WO 2006015715 A1 20060216; AU 2005270446 A1 20060216; BR PI0514123 A 20080527; CA 2575907 A1 20060216; CN 101035539 A 20070912; DE 102004038328 A1 20060316; EC SP077224 A 20070329; EP 1776120 A1 20070425; IL 181164 A0 20070704; JP 2008509101 A 20080327; KR 20070041613 A 20070418; MA 28811 B1 20070801; MX 2007001275 A 20090212; NO 20071231 L 20070503; RU 2007108078 A 20080920; US 2007299088 A1 20071227
DOCDB simple family (application)
EP 2005008057 W 20050723; AU 2005270446 A 20050723; BR PI0514123 A 20050723; CA 2575907 A 20050723; CN 200580034023 A 20050723; DE 102004038328 A 20040806; EC SP077224 A 20070205; EP 05764196 A 20050723; IL 18116407 A 20070205; JP 2007524224 A 20050723; KR 20077005245 A 20070305; MA 29696 A 20070221; MX 2007001275 A 20050723; NO 20071231 A 20070306; RU 2007108078 A 20050723; US 65962405 A 20050723